Celon Pharma S.A. (WSE: CLN)
Poland flag Poland · Delayed Price · Currency is PLN
26.00
-1.45 (-5.28%)
Nov 21, 2024, 5:03 PM CET

Celon Pharma Revenue

Celon Pharma had revenue of 120.01M PLN in the quarter ending September 30, 2024, with 148.34% growth. This brings the company's revenue in the last twelve months to 280.00M, up 30.55% year-over-year. In the year 2023, Celon Pharma had annual revenue of 213.92M with 10.33% growth.

Revenue (ttm)
280.00M
Revenue Growth
+30.55%
P/S Ratio
5.06
Revenue / Employee
494.70K
Employees
515
Market Cap
1.43B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023213.92M20.04M10.33%
Dec 31, 2022193.89M-2.20M-1.12%
Dec 31, 2021196.09M38.64M24.54%
Dec 31, 2020157.45M55.20M53.99%
Dec 31, 2019102.25M-23.00M-18.36%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Krka, d. d. 8.14B
NEUCA S.A. 12.34B
Sopharma AD 4.35B
Synektik Spólka Akcyjna 624.80M
Voxel S.A. 476.19M
Ryvu Therapeutics S.A. 91.18M
Selvita S.A. 329.02M
Centrum Medyczne ENEL-MED S.A. 680.32M
Revenue Rankings